Literature DB >> 18415777

Mycobacterium chelonae infection associated with adalimumab therapy.

F Díaz, J C Urkijo, F Mendoza, J M de la Viuda, M Blanco, A Unzurrunzaga, R Ayarza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18415777     DOI： 10.1080/03009740701716876

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer.

Authors:  Charles M Bark; Rana S Traboulsi; Kord Honda; Autumn M Starnes; Michael R Jacobs; Benigno Rodriguez
Journal:  J Clin Microbiol       Date:  2011-10-26       Impact factor: 5.948

Review 2.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 3.  Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

4.  Mycobacterium chelonae cutaneous infection: An opportunistic disease in an immunosuppressed patient with myasthenia gravis.

Authors:  Joana Granado; Ana Cláudia Miranda; Marco Fernandes; Luís Santos; Kamal Mansinho
Journal:  IDCases       Date:  2020-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.